Invicro

Quick facts

Marketed products

• Amyvid · Rare Disease

Phase 1 pipeline

• [18F]ABBV-964i
• [18F]ABBV-965i
• [18F]MK-0947
• [18F]MNI-1054
• [18F]MNI-1126
• [18F]MNI-1216
• [18F]MNI-444
• [18F] MNI-946
• [18F]MNI-958
• [18F]UCB-2897
• Lead Candidate
• PF-06412562

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Invicro portfolio CI brief
• Invicro pipeline updates RSS